Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a new date of February 6, 2025, while the previous date of January 23, 2025, has been removed.
    Difference
    6%
    Check dated 2025-02-10T09:29:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T05:43:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    New content was added on January 23, 2025, following the deletion of previous content on January 16, 2025.
    Difference
    0.3%
    Check dated 2025-01-27T02:39:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1 on January 16, 2025, following the removal of version 2.14.0 on December 4, 2024.
    Difference
    1%
    Check dated 2025-01-19T20:08:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    1.0%
    Check dated 2025-01-12T17:06:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:19:52.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.